Literature DB >> 3997254

[Levels of Latamoxef (moxalactam) in cerebrospinal fluid of newborns and premature newborns].

V von Loewenich, R Miething.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3997254     DOI： 10.1007/bf01660422

Source DB:  PubMed          Journal:  Infection        ISSN： 0300-8126            Impact factor:   3.553


× No keyword cloud information.
  8 in total

1.  Diffusion of a new beta-lactam (LY 127935) into cerebrospinal fluid. Implications for therapy of gram-negative bacillary meningitis.

Authors:  S H Landesman; M L Corrado; C C Cherubin; M Gombert; D Cleri
Journal:  Am J Med       Date:  1980-07       Impact factor: 4.965

2.  Pharmacokinetics and bacteriological efficacy of moxalactam (LY127935), netilmicin, and ampicillin in experimental gram-negative enteric bacillary meningitis.

Authors:  U B Schaad; G H McCracken; C A Loock; M L Thomas
Journal:  Antimicrob Agents Chemother       Date:  1980-03       Impact factor: 5.191

3.  [Cefotaxime and desacetylcefotaxime in cerebrospinal fluid of newborn and premature infants].

Authors:  V von Loewenich; R Miething; M Uihlein; H Knothe; M Greipel-Zamorski
Journal:  Padiatr Padol       Date:  1983

4.  [Gentamicin concentrations in cerebrospinal fluid of patients with inflamed and uninflamed meninges (author's transl)].

Authors:  O Brückner; M Alexander; F Martens
Journal:  Infection       Date:  1980       Impact factor: 3.553

5.  Pharmacokinetics and bacteriologic efficacy of moxalactam, cefotaxime, cefoperazone, and rocephin in experimental bacterial meningitis.

Authors:  U B Schaad; G H McCracken; C A Loock; M L Thomas
Journal:  J Infect Dis       Date:  1981-02       Impact factor: 5.226

6.  Pharmacokinetics and cerebrospinal fluid penetration of moxalactam in children with bacterial meningitis.

Authors:  S L Kaplan; E O Mason; H Garcia; S J Kvernland; E M Loiselle; D C Anderson; A A Mintz; R D Feigin
Journal:  J Pediatr       Date:  1981-01       Impact factor: 4.406

7.  Clinical evaluation of a new broad-spectrum oxa-beta-lactam antibiotic, moxalactam, in neonates and infants.

Authors:  U B Schaad; G H McCracken; N Threlkeld; M L Thomas
Journal:  J Pediatr       Date:  1981-01       Impact factor: 4.406

8.  Successful treatment of gram-negative bacillary meningitis with moxalactam.

Authors:  D A Olson; P D Hoeprich; S M Nolan; E Goldstein
Journal:  Ann Intern Med       Date:  1981-09       Impact factor: 25.391
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.